Susd4 Antibody

What is SUSD4 and why is it significant for cancer research?

SUSD4 is a complement regulatory protein that functions primarily as an inhibitor of the complement system and is involved in immune regulation. Recent studies have revealed its potential role in cancer progression. SUSD4 contains structural similarities to CD46, a membrane complement inhibitor that plays important roles in T cell function, suggesting SUSD4 may have comparable immunological functions .

The significance of SUSD4 in cancer research stems from findings that its expression correlates with prognosis in multiple cancer types. For instance, studies have shown that in breast cancer, higher SUSD4 expression is associated with differentiated tumors, decreased metastasis rates, and improved patient survival . Interestingly, SUSD4 exhibits a dualistic nature across cancer types - in some cancers, it appears to function as a tumor suppressor, while in others, high expression correlates with poorer outcomes .

How does SUSD4 expression vary across different cancer types?

SUSD4 expression demonstrates notable variability across cancer types, with significant prognostic implications:

This contradictory pattern suggests tissue-specific roles for SUSD4 in tumor biology and underscores the importance of cancer-specific investigation when using SUSD4 antibodies in research.

What are the main methods for detecting SUSD4 in biological samples?

Several complementary techniques are employed for detecting SUSD4 in research settings:

• Immunohistochemistry (IHC): Used for examining SUSD4 expression in tissue sections, particularly valuable for assessing expression in both tumor cells and tumor-infiltrating immune cells .

• Quantitative PCR (qPCR): Applied for measuring SUSD4 mRNA expression levels in tissue samples and cell lines .

• Western Blotting: Used to detect and quantify SUSD4 protein expression in cell lysates and tissue homogenates, valuable for confirming knockdown or overexpression efficiency .

• Flow Cytometry: Employed for analyzing SUSD4 expression at the cellular level, particularly useful when examining immune cell subsets.

• Immunofluorescence: Enables subcellular localization studies of SUSD4 and co-localization with other proteins of interest.

When designing experiments, researchers should consider the specific research question to determine the most appropriate detection method.

How does SUSD4 expression correlate with immune cell infiltration in tumors?

The relationship between SUSD4 expression and immune cell infiltration appears cancer-type dependent. Pan-cancer analysis revealed two distinct patterns :

• Positive Correlation: In colorectal adenocarcinoma (COADREAD), uveal melanoma (UVM), diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (LAML), liver hepatocellular carcinoma (LIHC), pheochromocytoma and paraganglioma (PCPG), and prostate adenocarcinoma (PRAD), SUSD4 expression positively correlates with most immune-related genes and immune cell infiltration.

• Negative Correlation: In low-grade glioma (LGG), breast invasive carcinoma (BRCA), bladder urothelial carcinoma (BLCA), mesothelioma (MESO), and lung squamous cell carcinoma (LUSC), SUSD4 expression negatively correlates with immune-related genes.

These patterns align with prognosis outcomes: when high SUSD4 expression correlates with poorer prognosis, it typically shows positive correlation with immune cell infiltration. Conversely, when high SUSD4 expression correlates with better outcomes, negative correlations with immune parameters are observed .

For researchers studying SUSD4 in the tumor microenvironment, it is essential to consider this context-dependent relationship when interpreting results from immunohistochemical staining or flow cytometry analyses of tumor samples.

What are the recommended controls when using SUSD4 antibodies in research?

When conducting experiments with SUSD4 antibodies, appropriate controls are critical for result validation:

• Positive Controls:

  • Use cell lines with confirmed high SUSD4 expression (e.g., DLD1 and LOVO colorectal cancer cell lines have shown high endogenous SUSD4 expression)

  • Include tissue sections known to express SUSD4 (e.g., differentiated breast cancer tissues)

• Negative Controls:

  • SUSD4 knockdown cells using validated siRNAs or shRNAs

  • Isotype control antibodies to assess non-specific binding

  • Tissues known to have minimal SUSD4 expression

• Specificity Controls:

  • Preabsorption with the immunizing peptide when available

  • Multiple antibodies targeting different epitopes of SUSD4 to confirm findings

• Technical Controls:

  • Secondary antibody-only controls to assess background staining

  • Loading controls for Western blot (e.g., β-actin, GAPDH)

  • Housekeeping genes for qPCR normalization

Properly controlled experiments enhance reproducibility and reliability of SUSD4-related research findings.

How can researchers validate SUSD4 antibody specificity?

Validation of SUSD4 antibody specificity is crucial for generating reliable research data. Recommended validation approaches include:

• Genetic Manipulation:

  • Compare antibody staining between wild-type cells and cells with SUSD4 knockdown (using siRNA/shRNA) or knockout (using CRISPR-Cas9)

  • Analyze cells overexpressing SUSD4 versus control-transfected cells

• Multi-method Validation:

  • Confirm concordance between protein detection (IHC/Western blot) and mRNA expression (qPCR)

  • Use multiple antibodies targeting different epitopes of SUSD4

• Cross-platform Validation:

  • Compare antibody detection with mass spectrometry results

  • Correlate antibody staining with RNA-seq data from the same samples

• Absorption Tests:

  • Pre-incubate antibody with purified SUSD4 protein or immunizing peptide

  • Verify elimination of specific signal

For quantitative applications, researchers should generate standard curves using recombinant SUSD4 protein to assess linearity of detection across the relevant concentration range.

How can researchers investigate interactions between SUSD4 and other proteins in cancer models?

Investigating SUSD4 protein interactions requires sophisticated methodological approaches:

• Co-Immunoprecipitation (Co-IP):

  • Use anti-SUSD4 antibodies to pull down SUSD4 and associated proteins

  • Analyze precipitated complexes by mass spectrometry to identify interacting partners

  • Validate findings with reverse Co-IP using antibodies against identified interaction partners

• Proximity Ligation Assay (PLA):

  • Visualize protein-protein interactions in situ with subcellular resolution

  • Particularly valuable for examining SUSD4 interactions with complement components or potential cancer-relevant binding partners

• Protein-Protein Interaction Network Analysis:

  • Utilize databases and computational tools to predict SUSD4 interactions

  • The STRING database has been used to construct protein-protein interaction networks for SUSD4

  • Visualize networks using software like Cytoscape, which has been applied in SUSD4 research

• Functional Validation:

  • Disrupt predicted interaction surfaces through site-directed mutagenesis

  • Assess the functional consequences of disrupted interactions on cellular phenotypes

Research has identified that SUSD4 interacts with pathways related to cancer progression and immune response, including JAK/STAT signaling . Pathway enrichment analyses suggest SUSD4 involvement in multiple cancer-related and immune-related pathways .

How does SUSD4 knockdown/overexpression affect cellular phenotypes in experimental models?

SUSD4 manipulation yields distinct phenotypic effects across experimental systems:

Knockdown Effects:

• In colorectal cancer models:

  • Reduced cell growth and colony formation in vitro

  • Decreased tumor volume and weight in subcutaneous xenograft models

  • Cell cycle alterations with increased G0-G1 phase and apoptotic cells, and decreased G2-M phase cells

  • Impact on the JAK/STAT pathway signaling

Overexpression Effects:

• In breast cancer models:

  • Attenuated cell migration and invasion capabilities

  • Inhibited colony formation when cultured on carcinoma-associated fibroblasts

  • This contrasts with colorectal cancer findings, highlighting context-dependent functions

In vivo Findings:

• Mouse models of breast cancer showed that tumors expressing SUSD4 had smaller volumes compared to mock control tumors

• Xenograft studies with SUSD4-knockdown colorectal cancer cells demonstrated reduced tumor growth

When designing SUSD4 manipulation experiments, researchers should:

• Confirm knockdown/overexpression efficiency at both mRNA and protein levels

• Use multiple independent clones or populations to control for clonal effects

• Employ appropriate cellular assays tailored to the cancer type being studied

• Consider context-dependent effects when interpreting results across different tumor types

How can contradictory findings about SUSD4's role in different cancer types be reconciled?

The seemingly contradictory roles of SUSD4 across cancer types present a complex research challenge. Several approaches can help reconcile these differences:

• Context-Dependent Analysis:

  • Examine SUSD4 in relation to tumor microenvironment composition

  • Analyze SUSD4 expression specifically in epithelial versus stromal compartments

  • Consider cancer subtype-specific effects, as molecular subtypes within a cancer type may respond differently to SUSD4 expression

• Multi-omics Integration:

  • Correlate SUSD4 expression with genomic alterations, transcriptomic profiles, and proteomic data

  • Identify co-expressed gene networks that may modify SUSD4 function

  • Apply computational approaches to identify context-specific factors that determine SUSD4's tumor-promoting or tumor-suppressive roles

• Pathway-Focused Investigation:

  • Research indicates SUSD4 expression correlates with different pathways across cancer types

  • In colorectal cancer, SUSD4 positively correlates with tumor inflammation, extracellular matrix processes, angiogenesis, epithelial-mesenchymal transition, p53 pathway, apoptosis, and TGF-β signaling

  • Conversely, SUSD4 negatively correlates with cancer proliferation, DNA repair, hypoxia response, DNA replication, MYC target genes, and G2M DNA damage checkpoint

  • These pathway correlations may explain the seemingly contradictory effects

• Experimental Models:

  • Develop complex models that more accurately recapitulate tumor heterogeneity

  • Use patient-derived organoids to maintain tissue-specific contexts

  • Consider the role of SUSD4 in tumor evolution and adaptation

Understanding SUSD4's dual nature requires researchers to move beyond simple expression analyses to consider its functional interactions within specific cellular and molecular contexts.

What techniques can be used to study SUSD4's impact on tumor microenvironment?

Studying SUSD4's influence on the tumor microenvironment (TME) requires sophisticated methodological approaches:

These approaches provide complementary insights into the complex relationships between SUSD4 expression and the tumor microenvironment across different cancer types.

What are the optimal experimental designs for studying SUSD4 in patient-derived samples?

When designing experiments to study SUSD4 in patient-derived samples, researchers should consider these methodological approaches:

Implementing these methodological considerations enhances the translational relevance of SUSD4 research and improves reproducibility across studies.

How can researchers optimize SUSD4 antibody-based experimental protocols?

Optimizing antibody-based protocols for SUSD4 detection requires careful consideration of several factors:

• Antibody Selection:

  • Choose antibodies validated for the specific application (IHC, WB, IF, FC)

  • Consider antibodies targeting different epitopes of SUSD4

  • Review literature for successfully used antibodies in similar applications

• Protocol Optimization for Western Blotting:

  • Determine optimal antibody concentration through titration experiments

  • Test different blocking reagents to minimize background

  • Optimize membrane transfer conditions for SUSD4's molecular weight

  • Consider specialized lysis buffers for membrane-associated proteins

• Immunohistochemistry Optimization:

  • Test multiple antigen retrieval methods (heat-induced vs. enzymatic)

  • Optimize primary antibody incubation conditions (temperature, duration, concentration)

  • Compare detection systems (DAB vs. fluorescent) for sensitivity and specificity

  • Validate results across different fixation protocols

• Flow Cytometry Considerations:

  • Determine whether surface or intracellular staining protocols are needed

  • Optimize permeabilization conditions if intracellular epitopes are targeted

  • Include appropriate compensation controls when multiplexing

• Quality Control Measures:

  • Implement lot-to-lot validation when receiving new antibody batches

  • Include both positive and negative controls in each experiment

  • Consider blind scoring of results when applicable

• Signal Amplification:

  • For low-abundance detection, consider tyramide signal amplification or other amplification methods

  • Validate that amplification does not introduce artifacts

Systematic optimization of these parameters will enhance detection sensitivity and specificity for SUSD4 across experimental platforms.

What are the emerging research questions regarding SUSD4 in cancer biology?

Several promising research directions warrant further investigation:

• Mechanistic Studies:

  • Elucidating the precise molecular mechanisms through which SUSD4 modulates tumor progression

  • Understanding how SUSD4 interacts with the complement system in the tumor microenvironment

  • Investigating SUSD4's role in modulating specific immune cell functions

• Therapeutic Potential:

  • Exploring SUSD4 as a potential therapeutic target, particularly in cancers where its expression correlates with poor prognosis

  • Drug sensitivity studies have shown correlations between SUSD4 expression and response to specific compounds including Selumetinib, YK-4-279, and Piperlongumine

  • Developing strategies to modulate SUSD4 expression or function

• Biomarker Development:

  • Validating SUSD4 as a prognostic biomarker across cancer types

  • Investigating SUSD4's potential as a predictive biomarker for immunotherapy response

  • Developing standardized assays for clinical application

• Context-Dependent Functions:

  • Resolving the seemingly contradictory roles of SUSD4 across different cancer types

  • Identifying the factors that determine whether SUSD4 promotes or suppresses tumor progression

  • Understanding the relationship between SUSD4 and tumor heterogeneity measures including MSI, TMB, MATH, and HRD

• Translational Applications:

  • Investigating SUSD4's utility in patient stratification for clinical trials

  • Exploring SUSD4 as a target for antibody-drug conjugates or immunotherapies

  • Developing SUSD4-based diagnostic tools

Addressing these questions will significantly advance our understanding of SUSD4's role in cancer biology and potentially lead to novel therapeutic strategies.